This article is more than 5 years old. Information may no longer be current.

FDA grants Visx marketing approval for mixed astigmatism

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SANTA CLARA, Calif. — Visx has received Food and Drug Administration marketing approval for another form of astigmatism treatment on its customized wavefront lasers, this time for mixed astigmatism, the company announced in a press release.

Visx noted it now has marketing approval on its CustomVue treatments for mixed astigmatism, myopia with astigmatism and hyperopia with astigmatism.

According to the press release, Visx is the only U.S. laser manufacturer to have approval for all forms of astigmatism.

Advanced Medical Optics and Visx agreed late last year to merge; the companies currently anticipate finalizing the deal in the second quarter.